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Acetylcholine in the brain has been associated with consciousness and general anesthesia effects. We tested
the hypothesis that the integrity of the nucleus basalis magnocellularis (NBM) affects the response to general
anesthetics. Cholinergic neurons in NBM were selectively lesioned by bilateral infusion of 192IgG-saporin in
adult, male Long–Evans rats, and control rats were infused with saline. Depletion of choline-acetyltransferase
(ChAT)-immunoreactive cells in the NBM and decrease in optical density of acetylcholinesterase (AChE)
staining in the frontal and visual cortices conﬁrmed a signiﬁcant decrease in NBM cholinergic neurons in
lesioned as compared to control rats. AChE staining in the hippocampus and ChAT-positive neurons in the
medial septum–vertical limb of the diagonal bandwere not different between lesioned and control rats.When
a general anesthetic was administered, lesioned compared to control rats showed signiﬁcantly longer duration
of loss of righting reﬂex (LORR) after propofol (5 or 10 mg/kg i.v.), pentobarbital (20 or 40 mg/kg i.p.) but not
halothane (2%). However, the behavioral excitation, as indicated by horizontal movements, induced by
halothane was reduced in lesioned as compared to control rats. Reversible inactivation of NBM with GABAA
receptor agonist muscimol increased slow waves in the neocortex during awake immobility, and prolonged
the duration of LORR and loss of tail-pinch response after propofol, pentobarbital and halothane. In summary,
lesion of NBM cholinergic neurons or inactivation of the NBM prolonged the LORR response to general
anesthetic drugs.
© 2011 Elsevier Inc. All rights reserved.
Introduction
Acetylcholine (Ach) in the brain has long been associated with
consciousness (Perry et al., 1999). Ach release was found to increase
during waking and rapid-eye movement sleep as compared to slow-
wave sleep (Vazquez and Baghdoyan, 2001; Phyllis, 2005). Choliner-
gic function is considered to be vital in attention, memory and other
cognitive processing (Everitt and Robbins, 1997; Sarter et al., 2005).
Cholinergic neuronal pathology, as found in Alzheimer's disease, is
accompanied by cognitive and behavioral deﬁcits (Whitehouse et al.,
1981; Guela and Mesulam, 1994; Bartus, 2000; Auld et al., 2002).
Cholinergic inputs to the cerebral cortex originate from neurons in
the basal forebrain, among which the nucleus basalis magnocellularis
(NBM) projects to the neocortical mantle, and medial septum–
diagonal band nuclei project to the hippocampus (Bigl et al., 1982;
Mesulam et al., 1983; Mckinney et al., 1983; Saper, 1984;Wenk, 1997;
Semba, 2000; Jones, 2004). The basal forebrain also contains
GABAergic and glutamatergic neurons that project to the cortex
(Gritti et al., 1997; Manns et al., 2003; Hassani et al., 2009). The basal
forebrain (Wenk, 1997; Detari et al., 1999; Cape and Jones, 2000;
Szymusiak et al., 2000; Lee et al., 2005), together with the thalamus
(Steriade, 2000; Dringenberg and Olmstead, 2003), is important for
cortical activation, manifested as a decrease in slow waves and an
increase in high-frequency oscillations.
General anesthesia is a reversible state of unconsciousness, during
which surgical operations may be performed, and the desirable
components are loss of response to pain, general awareness,
movement and memory without compromising vital functions
(Franks, 2008). Despite advances made on the molecular action of
various general anesthetics, such as their action on K+ channels,
GABAA, nicotinic and glutamate receptors (Franks, 2008), brain
structures underlying general anesthesia remain unclear. Anesthet-
ic-induced loss of consciousness was enhanced if arousal related brain
structures were ablated or inactivated (Devor and Zalkind, 2001;
Nelson et al., 2002; Flint et al., 2010; Franks, 2008; Kelz et al., 2008; Lu
et al., 2008; Luo and Leung, 2009), and sleep deprivation increased the
potency of propofol and isoﬂurane (Tung et al., 2002).
Experimental Neurology 228 (2011) 259–269
⁎ Corresponding author at: Dept Physiology and Pharmacology, Medical Sciences
Building, University of Western Ontario, London, ON, Canada N6A5C1. Fax: +1 519 661
3827.
E-mail address: sleung@uwo.ca (L.S. Leung).
0014-4886/$ – see front matter © 2011 Elsevier Inc. All rights reserved.
doi:10.1016/j.expneurol.2011.01.019
Contents lists available at ScienceDirect
Experimental Neurology
j ourna l homepage: www.e lsev ie r.com/ locate /yexnr
Author's personal copy
Relations between Ach and general anesthesia have emerged. An
anticholinesterase that increased central Ach levels was shown to
reduce the depth of anesthesia induced by propofol or isoﬂurane
(Meuret et al., 2000; Hudetz et al., 2003). Pain et al. (2000) reported
that central Ach depletion by intracerebroventricular (icv) adminis-
tration of 192IgG-saporin reduced the sedative potency of low-dose
(30 mg/kg i.p.) propofol, although a subsequent study (Laalou et al.,
2008) reported that the same depletion increased the anesthesia
potency of propofol (N100 mg/kg i.p.). Laalou et al (2008) concluded
that the main effect was mediated by immunotoxin lesion in the
medial septum/vertical diagonal band of Broca.
Consistent with the view that cholinergic neurons in the NBM
contribute to the maintenance of waking, we hypothesize that lesion
of NBM cholinergic neurons, or inactivation of the NBM, will enhance
the behavioral effects of a general anesthetic. Speciﬁc lesion of
cholinergic neurons in NBM was made by local infusion of 192IgG-
saporin, and inactivation of the NBM was made by local infusion of
muscimol, a GABAA-receptor agonist. Three general anesthetics,
halothane, pentobarbital and propofol were used, and the loss of
righting reﬂex (LORR) and the loss of tail-pinch pain responses,
together with neocortical EEG changes were measured. LORR in
animals after a general anesthetic drug is considered to be a measure
that corresponds to a loss of consciousness in humans (Franks, 2008).
Methods
Animals
Experiments were carried out on adult male Long Evans rats (250–
280 g; Charles River Canada). All animals were given water and regular
rat chow ad libitum and housed under climate-controlled conditions
with a 12 h light/dark cycle (lights on at 7:00 h). All procedures were
approved by the local Animal Use Committee and conducted according
to the guidelines of the Canadian Council for Animal Care.
Lesion of NBM
A rat was anesthetized with sodium pentobarbital (60 mg/kg i.p.)
and placed in a stereotaxic apparatus with bregma and lambda in a
horizontal plane. NBMwill refer to basal forebrain neurons that project
to the neocortex. Cholinergic neurons in the NBM lesion was made by
bilateral infusion of 192IgG-saporin (0.15 μg/0.5 μl/side or 0.5 μl of
1.44 μM solution in saline), via a 30-gage cannula, into substantia
innominata (SI) at posterior (P) 1.4 mm and lateral (L)±2.7 mm of
bregma, and 7.8 mm ventral (V) from the skull surface (Fig. 1; Paxinos
andWatson, 1998). Sham-lesion rats received bilateral saline infusion
(0.5 μl/side) into SI. The volume (0.5 μl) used was identical (Berntson
et al., 2002; Kaur et al., 2008), or similar (0.4–0.8 μl used by Heckers
et al., 1994; Laalou et al., 2008), to that used in other intra-NBM lesion
studies. Saline with or without 192IgG-saporin was delivered by an
infusion pump (Harvard Apparatus, South Natick, MA) over 10 min,
after which the cannula was kept in place for another 10 min to allow
for diffusion before retraction. Recording electrodes were inserted
bilaterally into the frontal cortex (FC; at anterior (A) 1.4, L2, V1.5, units
in mm), visual cortex (VC; P7, L3, V1.5), and hippocampus (bipolar
electrodes at P3.8, L2.7, V3 andV2). Each electrodewas a stainless steel
wire of 125 μm diameter insulated with Teﬂon except at the cut end.
The electrodes in the FC and VC were targeted at layer V of the cortex,
while the hippocampal electrodes were targeted to straddle the CA1
cell layer. Two screws placed over the cerebellum and frontal cortex
served as reference and ground electrodes respectively. Each electrode
was connected to an amphenol socket, which was then embedded
with the skull screws in dental cement on top of the rat's skull.
Fig. 1. Schematic diagram of coronal section 1.4 mm posterior to bregma (Paxinos and Watson, 1998) with superimposed choline acetyl transferase (ChAT) immunostained section
(right side) from a control, sham-lesion rat. Left side shows intended target of cannula delivering 192IgG saporin bilaterally (gray dotted circle), large (solid line) rectangle delimits
area for counting ChAT-immunopositive neurons, small (dashed line) rectangle for counting parvalbumin-immunopositive neurons. Right side shows putative cannula track in
sham-lesion rat, and ChAT-immunopositive neurons in magnocellular preoptic area (MCPO). MCPO, SI (substantia innominata), and f (fornix) on the left side as labeled in Paxinos
and Watson (1998); right side, corresponding structures in histological section.
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General anesthetic drug, EEG recording and behavioral tests
Response to anesthetics was tested in lesioned and control rats at
13–29 days after 192IgG-saporin/saline infusion. Three general
anesthetics – halothane, sodium pentobarbital and propofol – were
used, following procedures used in previous studies (Ma et al., 2002;
Ma and Leung, 2006; Long et al., 2009). Halothane (2%) in pure oxygen
was delivered by a calibrated vaporizer, at 8 l/min, into a Plexiglas
observation chamber (30×30×30 cm), and leaked through small
holes at the top. Sodium pentobarbital was injected at 20 or 40 mg/kg
i.p. and propofol at 5 or 10 mg/kg i.v.; the lower dose of each
anesthetic drug was below, and the higher dose was above, the typical
LORR in normal rats. The i.p. route of pentobarbital injection is widely
used for rodents. Intravenous propofol is the normal route used in
humans, and in Long–Evans rats, surgical anesthesia induced by
propofol required 15–20 times less dose i.v. than i.p. Two days before
propofol administration, the rat was given pentobarbital anesthesia,
and an intravenous catheter was placed into a femoral vein, threaded
under the body skin, and exteriorized above the skull. All rats were
given three anesthetics, with propofol administered as the last
anesthetic, while about equal number of rats received halothane or
pentobarbital ﬁrst; repeated administration of anesthetic drugs in one
rat was separated by at least two days. Control and lesion rats
followed the same sequence of anesthetic administration. For a
particular dose of an anesthetic, more than half the rats were done
with the experimenter unaware of the treatment of the rat, and
statistical signiﬁcance reported in the Results below remained when
only blinded experiments were included.
EEGs from one FC, one VC, and hippocampal electrodes were
recorded on a polygraph, and digitized and stored on a microcomputer.
Recordings were made during quiet-awake before an anesthetic drug,
and at various times after an anesthetic, in particular at a time showing
maximal effect of the drug (i.e., LORR), which was 10 min after
pentobarbital i.p. and 3 min after propofol i.v. EEG recordings were
not made after halothane anesthesia in the present study. All rats
retained spontaneous respiration after a general anesthetic.
As a measurement of the delirium, also known as stage II
anesthesia, induced by a volatile anesthetic (Guedel, 1951), horizontal
movements (locomotion) were quantiﬁed by measuring the number
of infrared beam interruptions after administration of halothane (Ma
et al., 2002; Long et al., 2009). Each lesioned or control rat was
habituated for 25 min in the chamber before the delivery of halothane
(2%). The number of infrared beam interruptions was stored for the
period of 5 min prior to, and 10 min after halothane administration.
Behavioral tests after a general anesthetic consisted of pain and
righting responses. The same experimenter was involved in the
behavioral tests of a given anesthetic. Pain response to tail pinch was
tested. A positive pain response was considered to be a movement of
the body or more than one limb in response to the pinch by an
alligator clip on the tail. The pinch was applied periodically to the
middle part of the tail but not to the same part successively. A tail
pinch induced a normal rat to move but caused no permanent tissue
damage. The righting reﬂex was considered normal when the rat
could right itself from a supine position. After exposure to halothane
in the observation chamber for 10 min, pain and righting responses
were tested in room air. Tests were made starting 5 min after
pentobarbital (i.p.) injection and immediately after propofol (i.v.)
injection. Rats that did not lose their righting were not tested for pain
response, since they were shown always to retain positive pain
responses (with a minimal pinch to the tail).
Inactivation of NBM
A separate group of 16 ratswas studied aftermuscimol inactivation
of the NBM. These rats were implanted with hippocampal and frontal
cortical electrodes, as above. In addition, guide cannulae (23-gage)
were implanted bilaterally over NBM (P1.4, L±2.7). At least 7 days
after surgery, experiments were performed in rats that were
habituated to the laboratory environment. A 30-gage cannula was
lowered into the guide cannula to the depth of the NBM (V7.8), and
muscimol (0.4 μg in 0.4 μl saline, 9.8 mM) or 0.4 μl of saline was
infused bilaterally. Infusionwasmademanually by a Hamilton syringe
at a rate of ~0.5 μl/min, and EEG recordings (below)weremade before
and after infusion. Administration of a general anesthetic drug was
made 10 min aftermuscimol or saline infusion in the NBM.Halothane-
induced movements were studied by measuring infrared beam
interruptions in a chamber following muscimol/saline infusion into
the NBM (at 10 min before onset of halothane administration), for
4 min before and 10 min after halothane delivery.
Histological and immunocytochemical staining
At the end of experiments, saporin and sham lesioned rats were
given a surgical anesthetic dose of pentobarbital and perfused through
the heart with 100 ml of 0.9% saline followed by 500 ml of 4%
paraformaldehyde solution (Sigma) in 0.1 M phosphate buffer (PB;
pH 7.4). The rat brain was removed and postﬁxed with 18% sucrose in
phosphate-buffered saline for 24 h at 4 °C. Coronal brain sections of
40-μm thick were cut by a freezing microtome. Electrode and cannula
locations were veriﬁed from thionin-stained sections. The degree of
preservation of cholinergic ﬁbers in the neocortex and hippocampus
was assessed by acetylcholinesterase (AChE) histochemistry (Leung,
1987). AChE staining protocol was modiﬁed from the Koelle copper
thiocholine method (Koelle and Friedenwald, 1949), using acetylthio-
choline iodide as a false substrate to tag the AChE enzyme and
ethopropazine as an inhibitor of non-speciﬁc cholinesterases Digital
photographs were taken using the same parameters (microscope
lighting, digital camera aperture and shutter speed settings) at FC
(~A2), VC (~P7.3), parietal cortex (~P3) and dorsal hippocampus
(~P3). A computer software program (ImageJ, National Institutes of
Health, U.S.A.) was used to quantify AChE staining by means of an
average optical density (OD) measure on one side. The OD average
was taken from a rectangular window. For the FC and VC, the window
was 1.5–2 mmwide (medial edge at ~L1.5–2), and included layers I to
V; for the hippocampus, it was 1–1.5 mm wide and included layers
from the alveus to stratum lacunosum-moleculare of hippocampal
CA1.
Choline acetyltransferase (ChAT) and parvalbumin (PARV) immu-
nocytochemistry, using procedures described before (Ma et al., 2004),
were performed on coronal sections through the basal forebrain.
Brieﬂy, the sections were rinsed in PB and incubated at 4 °C for 48 h in
primary antibody solution containing mouse monoclonal ChAT
(1:200; Biogenesis) or mouse monoclonal PARV (1:2000; Sigma) in
1% normal goat serum. Sections were washed in three changes of PB
and followed by biotin-conjugated goat anti-mouse secondary
antiserum (1:200; BioCan) for 1 h in room temperature. After rinsing
several times in PB, the sections were incubated in an ABC complex
solution (Vector Laboratories) for 1 h at room temperature, and
enhanced in a solution containing 0.05% diaminobenzidine tetrahy-
drochloride (DAB, Sigma) and 0.003% hydrogen peroxide in PB at
room temperature. Digital pictures were made at 40× and 100×
magniﬁcation of coronal brain sections through NBM and medial
septum. ChAT immunopositive (cholinergic) neuronal cell bodies in
the horizontal limb of the diagonal band (HDB)/magnocellular
preoptic area (MCPO)/SI area of each side (~P1.4 and ~P0.8 of Paxinos
and Watson, 2009) were counted on left and right sides in a 4 mm
wide×3 mm high window (starting at L0.5; Fig. 1); neurons clearly
within caudate–putamen were not counted. Medial septum and
vertical limb of the diagonal band neurons (ChAT or PARV) were
counted bilaterally in a section at ~A0.5. PARV immunopositive
neurons were counted in a 1.6 mm×1.2 mm window that included
the HDB/MCPO just lateral to the optic tract (~P1.4; Fig. 1), excluding
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neurons in the caudate–putamen. The persons doing the cell counting
were blind to the treatment of the rats. Selected sections recounted by
the same or a different person showed high reproducibility.
Data analysis
Artifact free EEG, digitized at 200 Hz, was selected for power
spectral analysis (Leung, 1985). Each EEG segment consisted of 1024
points (5.12 s), and 6–12 segments were used for each power
spectrum consisting of N60 degrees of freedom after smoothing
across frequency bins (frequency resolution 0.19 Hz, independent
bins every 0.78 Hz). Records with prolonged high-voltage spindle
activity (6–11 Hz) in the neocortex during quiet-awake were not
included for power spectral analysis. The average integrated power of
the EEG was determined at different frequency ranges by averaging
the power across frequency bins within the range of delta (0.8–4 Hz),
theta (4–10 Hz), beta (13–32 Hz), low gamma (32–58 Hz) and high
gamma (62–100 Hz). Power was determined in logarithmic units, and
4.8 log units of power were equivalent to a 0.5 mV peak-to-peak sine
wave.
Wilcoxon signed-rank test was used for statistical testing.
Parametric statistics were not applied to samples showing no variance
(e.g., zero LORR duration in the whole group), or inhomogeneous
variance (movement data). Pearson correlation coefﬁcients were
calculated between pairs of histological and behavioral measures.
Group data are presented as mean±standard error of the mean
(SEM). Differences were considered signiﬁcant if Pb0.05.
Results
Cholinergic markers were decreased in 192IgG-saporin lesion of the NBM
In the group of lesioned rats infused with 192IgG-saporin (n=9), a
decrease in AChE stain intensity was found in the lateral neocortex, as
compared to the control, sham-lesioned rats infusedwith saline (n=6;
Figs. 2A and D). This was conﬁrmed by optical densitymeasurements in
frontal, parietal and visual cortices (Table 1). On the other hand, the
AChE staining of the dorsal hippocampus in the saporin-lesioned rats
was not statistically different from that of control, sham-lesioned rats
(Figs. 2A andD; Table 1). The number of ChAT immunoreactive neurons
in the HDB/MCPO/SI (at P1.4)was signiﬁcantly decreased in lesioned as
compared to control rats (Figs. 2C and F; Table 2). As a group, the
average number of ChAT-immunoreactive neurons in saporin-lesioned
rats was estimated to be 38% of that in sham-lesioned rats at P1.4
(Table 2, 6 sham-lesion and 9 saporin-lesion rats), and 55% of that in
sham-lesioned rats at P0.8 (5 sham-lesion and 8 saporin-lesion rats).
The number of ChAT immunoreactive neurons in NBM (total counted in
both P0.8 and P1.4 sections) was signiﬁcantly correlated with the
average AChE staining intensity in the FC (correlation coefﬁcient
r=0.72, Pb0.01, n=13 rats). By contrast, the number of ChAT
immunoreactive neurons in the medial septal/vertical limb of the
diagonal band area was not different between control and lesioned rats
(Figs. 2B and E; Table 2). In addition, there was no difference in the
number of PARV immunoreactive neurons in the horizontal limb of the
diagonal band at ~P1.4 between control and lesioned rats (Table 2).
Propofol's anesthetic effects were prolonged in lesioned rats
In both lesion and control rats, the EEG at the electrodes at the FC
and VC showed low-voltage fast activity during awake-immobility, as
compared to high-voltage, slow wave activity during slow wave sleep
(data not shown). High-voltage spindle activity (6–11 Hz) during
awake-immobility showed similar incidence in control and lesion
rats, and slow EEG power (delta activity) excluding periods of high-
voltage spindle activity did not differ between control and lesioned
rats. Lesioned rats did not show any signs of sedation; they were
responsive to touch, sound, and light like control rats and were
capable of righting themselves. Differences between lesioned and
control rats emerged only after administration of a general anesthetic
drug.
Propofol (5 mg/kg i.v.) induced a brief period of LORR in most
control rats, but 2 of 6 rats retained righting; the duration of LORR
averaged 2.5±1.2 min (n=6, including the 2 rats that retained
righting). In contrast, all lesioned rats showed a LORR immediately
after 5 mg/kg i.v. propofol, and the duration of LORR was 11.8
±0.9 min (n=9), signiﬁcantly longer than that in control rats
(Pb0.005, Wilcoxon; Fig. 3A). Only 2 of 6 control rats lost tail-pinch
pain response after propofol, and the average duration of lost pain
response was 1±0.6 min (n=6) for control rats. However, all
lesioned rats showed a loss of tail pinch response after propofol,
with the duration of loss averaging 5.9±0.8 min (n=9), signiﬁcantly
longer than that in control rats (Pb0.005, Wilcoxon). When given
10 mg/kg i.v. propofol, lesioned rats also showed a signiﬁcantly longer
duration of LORR as compared to control rats (Fig. 3B).
At 3 min after 5 mg/kg i.v. propofol, the EEG at the FC and VC
showed increased slow waves, compared to baseline immobility, in
association with the LORR in the lesioned rats (Fig. 4B1 and B2), and
conﬁrmed by power spectral analysis (* in Fig. 4B3). By contrast, the
EEG in the control rats treated with propofol was mainly unchanged
(Fig. 4A), except for a small but signiﬁcant increase in gamma of 50–
100 Hz (arrow in Fig. 4A3). When lesioned and control groups of rats
were compared for power at the FC electrode, the post-propofol
increase in integrated delta (0.8–4 Hz) EEG power was signiﬁcantly
larger in lesioned rats than control rats (Pb0.02, Wilcoxon; Table 3),
while the increase in high-frequency gamma (62–100 Hz) power was
signiﬁcantly larger in control than lesioned rats (Pb0.02, Wilcoxon;
Table 3). A similar trend was observed at the VC electrode, but the
difference in delta or gamma power in VC after propofol was not
statistically signiﬁcant between lesioned and control rats (Table 3).
Pentobarbital induced more prolonged loss of righting in lesioned rats
Sodium pentobarbital (20 mg/kg i.p.) induced LORR averaging
32.5±4.5 min in control rats (n=6), as compared to 64.3±7 min
(n=9) in lesioned rats (Pb0.005, Wilcoxon; Fig. 3C). The duration of
loss of tail pinch responses was not different between control and
lesioned groups (Fig. 3C). Pentobarbital (20 mg/kg i.p.) induced a
signiﬁcant increase in delta activity and a decrease in 62–100 Hz
gamma power, at both FC and VC electrodes, in both control and
lesioned rats (data not shown). A higher dose of sodium pentobarbital
(40 mg/kg i.p.) induced a longer duration of LORR and loss of tail-
pinch response in lesioned rats as compared to control rats (both
Pb0.05, Wilcoxon; Fig. 3D).
Halothane induced less locomotion but no change in LORR duration in
NBM lesioned rats
In order to test the behavioral excitation induced by halothane,
horizontal movements were measured before and after 2% halothane
delivery. During the baseline before halothane, the infrared beam
interruptionswere few (Fig. 3F) and not signiﬁcantly different between
lesioned and control rats (5 min of baseline, PN0.6,Wilcoxon).When2%
halothane was administered to habituated control rats, they sniffed,
made head movements, and moved around the observation chamber
vigorously, evenwhen theywere ataxic. By contrast, some lesioned rats
did not move after halothane administration. Rats stopped making
voluntary movements 5–8 min after 2% halothane, and the time of
movement cessationwas not statistically different between control and
lesioned rats. However, movements during halothane, as indicated by
thenumber of infraredbeam interruptions,were signiﬁcantlydecreased
in lesioned rats, as compared to control rats (total interruptions for ﬁrst
4 min during halothane, Pb0.01, Wilcoxon).
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After 10 min of exposure to 2% halothane, rats were removed from
the chamber into room air, and periodically tested for responses to tail
pinch and righting, until each response recovered. There were no
signiﬁcant differences between lesioned and control rats in the
duration of lost tail-pinch or righting response (Fig. 3E; PN0.05,
Wilcoxon).
Correlation between histological and behavioral measures
Pearson correlation coefﬁcients were calculated between AChE
intensity in FC (averaged across both sides) to other histological and
behavioral measures (Table 4). When all (6 control and 9 lesioned)
rats were included, AChE intensity in FC was negatively correlated
Fig. 2. Representative histological sections of sham-lesion control (left column, A–C) and 192IgG saporin-lesion rat (right column, D–F). As compared to the control rat
(A), acetylcholinesterase (AChE) stain in the lateral neocortex, but not in the hippocampus, was strongly reduced in the lesion rat (D). Choline acetyl transferase (ChAT) immunoreactive
neurons in the medial septum–vertical limb of the diagonal band area were similar in numbers in control (B) and lesion (E) rats. ChAT-immunoreactive neurons in the horizontal limb of
the diagonal band/magnocellular preoptic area (nucleus basalis magnocellularis at ~P1.4) were greatly reduced in the lesion rat (F) as compared to the control rat (C).
Table 1
Optical density (OD) of acetylcholinesterase (AChE) staining in the frontal, parietal and
visual cortex, and dorsal hippocampus (CA1 area) of control sham-lesion and saporin-
lesion rats. A dark AChE stain has been converted to a high OD value, with zero = pale
and 255 = dark. OD values were averaged across left and right sides of one section per
rat, and mean and standard error of the mean of the group are shown. **Pb0.01,











170.5±7.8 154.1±5.1 150.3±9.0 157.9±4.9
Saporin lesion (n=9) 117.3±4.0** 126.8±2.6** 131.0±8.1* 152.6±6.1NS
Table 2
Neuronal counts of putative cholinergic and GABAergic neurons in the basal forebrain.
Putative cholinergic neurons were immunoreactive to choline acetyltransferase (ChAT)
and putative GABAergic neurons were immunoreactive to parvalbumin (PARV).
Immunopositive neurons in the nucleus basalis magnocellularis (NBM) were counted
bilaterally in the magnocellular preoptic area/horizontal limb of the diagonal band/
substantia innominata areas at ~P1.3, without including neurons within the caudate–
putamen (see Methods for details). ChAT neurons in the medial septum/diagonal band
of Broca (MS/DBB) were counted bilaterally at ~A0.5; n = number of rats. **Pb0.002,







Control sham 173±14 (n=6) 130±19 (n=5) 278±25 (n=6)
192 IgG-saporin
lesion in NBM
66±15** (n=9) 139±11 (n=9)NS 279±19 (n=9)NS
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with, after Bonferroni adjustment for multiple comparisons, the
duration of loss of pain after propofol (Pb0.05) and the duration of
LORR after propofol (Pb0.01).
Muscimol infusion in the NBM
In order to extend the validity of cholinergic lesion of the NBM, a
reversible lesion was made by infusion of muscimol into the NBM and
compared with infusion of saline into the NBM of the same rat. No
signiﬁcant change in neocortical EEG was detected when 0.4 μl saline
was infused bilaterally into the NBM (data not shown). However, less
than 5 min after bilateral infusion of muscimol (0.4 μg in 0.4 μl saline
per side) into the NBM, slow EEG waves appeared at FC and VC
electrodes during awake immobility (Fig. 5). Spectral analysis revealed
that the slow EEG was mainly within the delta frequency band
(Fig. 5B), and the integrated delta power during awake immobilitywas
signiﬁcantly (Pb0.05, Wilcoxon) increased after muscimol, as com-
pared to baseline, by 1.15±0.16 (n=6) and 0.65±0.18 (n=6)
logarithmic units at the FC andVC electrode respectively. Gammaband
(30–100 Hz) power during IMM was not signiﬁcantly changed after
muscimol infusion (Fig. 5B). Despite the presence of slow waves
during IMM, the rat was not behaviorally asleep and it maintained
intact righting and pain responses. The slow EEG after muscimol was
desynchronized when spontaneous movements occurred (data not
shown).
Propofol (5 mg/kg i.v.) was injected 10 min after bilateral infusion
of saline ormuscimol in theNBM. Propofol administration resulted in a
signiﬁcantly longer duration of LORR (Pb0.05, Wilcoxon) when given
after muscimol-NBM infusion (26.5±11.3 min, n=10), as compared
to the same rats after saline-NBM infusion (2.7±1.0 min, n=10;
Fig. 6A). Similarly, propofol induced a longer duration (Pb0.05,
Wilcoxon) of loss of tail-pinch response in the muscimol-infused
group (3.2±0.8 min n=10), as compared to the saline-infused group
(0.2±0.2 min, n=10; Fig. 6A). Neocortical delta EEG was further
increased by propofol after NBM muscimol-infusion (Fig. 5C), but the
propofol-induced increase was small in muscimol- as compared to
saline-infused rats (data of saline-infused rat not shown, but was
similar to control rat in Fig. 4A).
NBM inactivation bymuscimol also resulted in a prolongation of the




Fig. 3. Cholinotoxin (192IgG-saporin) lesion as compared to control (sham) lesion of the nucleus basalis magnocellularis enhanced response to propofol (5–10 mg/kg i.v.) and
pentobarbital (20–40 mg/kg, i.p.) but not to halothane (2%). Lesion rats, as compared to control rats, showed a signiﬁcant increase in duration of loss of righting reﬂex after propofol
(A, B) and pentobarbital (C, D), and an increase in the duration of loss of tail-pinch response to 5 mg/kg i.v. propofol (A) and 40 mg/kg i.p. pentobarbital (D). **Pb0.01, *Pb0.05,
Wilcoxon test. E. No differences in tail-pinch and righting responses were seen between lesion and control rats during emergence from 2% halothane. (F) The number of horizontal
movements induced by halothane (2%) was smaller in lesion as compared to control rats (*Pb0.05, Wilcoxon test for ﬁst 4 min after halothane). Horizontal movements were
detected by interruptions of infrared beams, for 5 min before and 10 min after 2% halothane administration. All experiments used six control rats and 9 lesion rats, except 4 control
and 4 lesion rats in experiments shown in parts B and D. All values are mean±SEM.
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In rats given saline infusion into the NBM, pentobarbital sedated the
animals, but with little LORR and no loss of tail-pinch response. In rats
given 0.4 μg muscimol bilaterally in the NBM, pentobarbital induced a
durationof LORRof 55.1±16.8 min (n=6)and adurationof loss of tail-
pinch response of 9.4±8.1 min (n=6), signiﬁcantly different from the
respective duration after saline-NBM infusion (Pb0.05, respectively,
Wilcoxon; Fig. 6B).
Horizontal movements induced by 2% halothane, as assessed by
infrared beam interruptions, were recorded in 6 rats after saline or
muscimol infusion into the NBM. During the 4 min before halothane,
muscimol-infused rats showed a smaller number of movements than
saline-infused rats (Pb0.05, pairedWilcoxon, total beam interruptions
during baseline; Fig. 6D). The increase in beam interruptions induced
by halothane in the ﬁrst 4 min, above the 4-min baseline, was
signiﬁcantly smaller in muscimol-infused as compared to saline-
infused rats (Pb0.03, paired Wilcoxon). All saline-infused rats
increased movements after halothane, but some muscimol-infused
rats did not move after halothane administration.
A more prolonged anesthesia response to 2% halothane was found
after muscimol- as compared to saline-infusion in the NBM. Saline-
infused rats showed durations of loss of righting and tail-pinch
response (in room air after 10 min in 2% halothane) of 134.3±81.4
and 32.5±7.2 s, respectively (both n=6; Fig. 6C). Muscimol-infused
rats had durations of loss of righting and tail-pinch following
halothane of 1258±199 and 190±50 s, respectively (both n=6;
Fig. 6C), signiﬁcantly longer than the respective measure after saline-
infusion (Pb0.05, respectively; Fig. 6C).
Discussion
We showed that a localized loss of the NBM cholinergic neurons,
sparing the septohippocampal cholinergic neurons, prolonged LORR
induced by propofol and pentobarbital, and reduced the behavioral
excitation during 2% halothane. Muscimol infusion into the NBM
greatly prolonged the duration of loss of righting and tail-pinch
response after propofol, pentobarbital and halothane.
Infusion of 0.15 μg 192IgG-saporin in the NBM resulted in an
estimated loss of 45–62% of ChAT-immunopositive (cholinergic)
neurons in the NBM, within 0.6 mm from the infusion site. This
compares well with a 69% loss of cholinergic neurons after infusion of
0.26 μg 192IgG-saporin in the NBM (Kaur et al., 2008). No signiﬁcant
change in the number of PARV-immunopositive neurons in the NBM
was found in the present study, conﬁrming the selectivity of 192IgG-
saporin on cholinergic neurons (Heckers et al., 1994; Wenk et al.,
1994; Kaur et al., 2008).
Acetylcholine and neocortical activation
In this study, no difference in slow EEG during awake-immobility
was found between 192IgG-saporin lesion rats and control rats, as has
A.
B.
Fig. 4. EEG traces and power spectra of representative control and 192IgG-saporin lesion rats before and after propofol (5 mg/kg i.v.). Both control (A) and lesioned rat (B) showed
desynchronized EEG in the frontal cortex (FC) and visual cortex (VC) before propofol (column 1). The control rat showed no loss of pain and righting responses, andminimal changes
in the EEG, after propofol. In contrast, propofol resulted in a loss of pain and righting response in the lesioned rat, accompanied by an increase in slow EEG waves (column 2). Post-
propofol EEG power spectra in FC (column 3) showed a slight increase in gamma power (arrow) in the control rat, and a large increase in slow EEG power (*) in the lesion rat, as
compared to pre-propofol (baseline); 60-Hz artifacts were removed in power spectra.
Table 3
Changes in EEG logarithmic power 3–5 min after propofol (5 mg/kg i.v.) for different frequency bands of delta (δ), low gamma γ (30–58 Hz) and high gamma γ (62–100 Hz) at the
frontal and visual cortex electrodes of control, sham-lesion rats and rats with 192IgG-saporin lesion in the nucleus basalis magnocellularis. #Pb0.05, signiﬁcant change in power
before and after drug for a particular group; *Pb0.05, signiﬁcant difference in power change between lesion and control groups.
Propofol (5 mg/kg i.v.)
Sham control (n=6) Saporin-lesion (n=9)
δ change Low γ change High γ change δ change Low γ change High γ change
Frontal cortex 0.35±0.11# 0.45±0.10# 0.22±0.07# 0.78±0.14#* 0.34±0.09# −0.06±0.02#*
Visual cortex 0.38±0.16 0.34±0.05# 0.04±0.06 0.39±0.09# 0.26±0.05# −0.0±0.06
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been previously reported (Wenk et al., 1994; Berntson et al., 2002;
Kaur et al., 2008). In addition, Blanco-Centurion et al. (2006) reported
that NBM lesion by 192IgG-saporin resulted in no change in sleep
drive or the daily amounts of sleep–wake activities.
Neocortical low-voltage fast activity during quiet-awake was
replaced by high-amplitude slow waves after infusion of muscimol
into the NBM (Fig. 5). Muscimol, a GABAA receptor agonist, is expected
to hyperpolarize and inactivate both cholinergic and non-cholinergic
neurons. Similar increase in high-amplitude slow waves in the
neocortex during quiet-awake was found after permanent lesion of
the NBM by kainic or ibotenic acid (Stewart et al., 1984; Buzsaki et al.,
1988), which ablated both cholinergic and non-cholinergic neurons
in the NBM (Kaur et al., 2008). Neocortical slow waves were also
reported after administration of procaine into theNBM(Cape and Jones,
2000).
Despite the presence of neocortical slow-waves after muscimol
infusion into the NBM, the rat was behaviorally awake and showed no
signs of general anesthesia, i.e., its righting and pain responses were
intact. This illustrates a dissociation of cortical slow-waves from sleep
and general anesthesia. A dissociation of slow waves and sleep had
been reported after atropine (Wikler, 1952; Vanderwolf, 1988) or
muscimol injection into the pontine reticular formation (Flint et al.,
2010), which suggests the fallacy of using EEG as the sole indicator of
a behavioral state. On the other hand, large neocortical slow waves
were typically associated with LORR induced by an anesthetic drug
(Fig. 4B).
Acetylcholine, NBM and general anesthesia
One main original result reported here was that cholinotoxin lesion
of the NBM prolonged the duration of LORR following several general
anesthetics, including propofol (5–10 mg/kg i.v.) and pentobarbital
(20–40 mg/kg i.p.). In contrast, lesion of the NBM cholinergic neurons
by 192IgG-saporin did not prolong the emergence from halothane
anesthesia. The difference between anesthetic drugs may depend on
their different molecular actions (Pittson et al., 2004; Franks, 2008) on
various types of NBMneurons. In the present study, delayed emergence
fromhalothane anesthesiawas found aftermuscimol inactivation of the
NBM, suggesting that inactivation of non-cholinergic NBMneuronsmay
A. B. C.
Fig. 5. Neocortical EEG slow waves during awake-immobility were enhanced after infusion of GABAA receptor agonist, muscimol (Mus), into the nucleus basalis magnocellularis
(NBM), and further by administration of propofol. EEG recorded in the frontal cortex (FC) and visual cortex (VC) before (A, baseline), and 10 min after bilateral infusion of muscimol
(0.4 μg in 0.4 μl saline) into the NBM (B, muscimol), and then 5 min after injection of 5 mg/kg i.v. propofol (C, Mus+propofol). The administration of propofol after NBM-muscimol
infusion further enhanced slow waves in the FC and VC.
Table 4
Pearson correlation coefﬁcients between average acetylcholinesterase (AChE) intensity
at the frontal cortex, averaged across both sides, with other histological and behavioral
measures from 6 control and 9 lesion rats. High AChE intensity corresponds to a large
number (Table 1). NBM, nucleus basalis magnocellularis; ChAT, choline acetyltransfer-
ase; LORR, loss of righting response. **Pb0.01, *Pb0.05, Bonferroni adjusted probability.




Number of ChAT immunopositive neurons in NBM (~P1.4) 0.78**
Average AChE intensity in the visual cortex 0.94**
Propofol induced duration of loss of tail-pinch response −0.72*
Propofol induced duration of LORR −0.83**
Pentobarbital induced duration of loss of tail-pinch response −0.13
Pentobarbital induced duration of LORR −0.54
Halothane induced infrared beam interrupts in ﬁrst 5 min −0.62
Halothane induced duration of loss of tail-pinch response −0.11
Halothane induced duration of LORR −0.25
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be required for delayed emergence from halothane anesthesia.
Preliminary data also showed that kainic acid infusion into the NBM
depleted both ChAT- and PARV-immunopositive neurons and pro-
longed the emergence from halothane anesthesia (Leung and Petro-
poulos, unpublished data).
Stage II anesthesia induced by a volatile anesthetic is characterized
by delirium or behavioral excitation (Guedel, 1951). We showed that
the delirium induced by halothane was reduced by cholinergic lesion
or muscimol-inactivation of the NBM. However, delirium but not
emergence time was affected by NBM cholinergic lesion, suggesting
that the mechanisms underlying delirium and anesthesia emergence
are different. Muscimol-inactivation of the medial septum, hippo-
campus and connected limbic areas (Ma et al., 2002; Ma and Leung,
2006; Long et al., 2009) were shown to reduce delirium and increase
emergence time from halothane anesthesia.
This study provides original evidence that cholinergic neurons in
the NBM are important in the behavioral responses to general
anesthetics. The results are generally consistent with previous studies.
Increasing central Ach levels is known to reduce the depth of
anesthesia (Meuret et al., 2000; Hudetz et al., 2003). Laalou et al.
(2008) reported that NBM lesion with 192IgG-saporin increased the
anesthetic, but not the subanesthetic, effects of cumulative doses of
propofol (i.p.). We showed that 5 mg/kg i.v. propofol resulted in
surgical anesthesia (loss of both tail-pinch and righting responses) in
all NBM 192IgG-saporin lesioned rats but not in any of the control rats.
Thus, injection through the usual route of administration of propofol
(i.v.) potentiated the effect of a subanesthetic dose.
The participation of the NBM in general anesthetic responses likely
involves the projection of NBM to the thalamus and neocortex, but
downstream projections from the NBM to the hypothalamus and
brainstem (Semba, 2000) may also be involved. NBM projects to
arousal promoting neurons in the hypothalamus (containing hista-
mine or orexin), locus coeruleus, raphe, andmesencephalic locomotor
region (MLR; Mogenson et al., 1993), mainly through GABAergic
connections (Semba, 2000). A nucleus accumbens–subpallidum
(NBM)–MLR pathway (Mogenson et al., 1993) is a possible route
that the limbic systemmodulates the effects of general anesthesia (Ma
et al., 2002; Ma and Leung, 2006). MLR inactivation has been shown to
decrease the minimum alveolar concentration of isoﬂurane in rats
(Jinks et al., 2010).
Lesion or inactivation of various brain structures other than NBM
was shown to prolong the duration of LORR induced by general
anesthetics. Inactivation of the medial septum, hippocampus, nucleus
accumbens, ventral pallidum, ventral tegmental area and supramam-
millary area prolonged the LORR induced by both pentobarbital and
halothane (Ma et al., 2002; Ma and Leung, 2006), while inactivation of
the entorhinal cortex and piriform cortex mainly prolonged the LORR
induced by pentobarbital but not halothane (Long et al., 2009).
Infusion of muscimol into the mesopontine tegmentum (Devor and
Zalkind, 2001) or tuberomammillary nucleus (Nelson et al., 2002)may
induce LORR. Like the NBM, inactivation of a brain structure may
enhance general anesthetic responses by inﬂuencing sleep–wake
circuits. Whether several structures, when inactivated, may affect one
or several sleep–wake circuits remain to be studied.
This study demonstrates that a loss of cholinergic basal forebrain
neurons increases the time of emergence for some general anesthetics.
Whether this applies to general anesthesia in aged humans and
Alzheimer's patients (Fodale et al., 2006) remains to be investigated.
A. B.
C. D.
Fig. 6.Muscimol, as compared to saline, infusion in the nucleus basalis magnocellularis (NBM) prolonged the duration of lost response to tail-pinch and righting in rats after A) propofol
5 mg/kg i.v., B) sodium pentobarbital (20 mg/kg i.p.), and C) halothane (2%). D) The number of infrared beam interruptions (horizontal movements) induced by halothane (2%) was
smaller in rats pre-treatedwithmuscimol as compared to saline in the NBM (*Pb0.05,Wilcoxon test for ﬁst 4 min after halothane). Muscimol (0.4 μg in 0.4 μl saline), or 0.4 μl saline, was
infused bilaterally into theNBM10min before administration of an anesthetic drug. *Pb0.05, pairedWilcoxon, differencebetween saline andmuscimol-infused groups. Six ratswere used
in each experiment (B, C and D) except 10 rats were given propofol (A).
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Aging is associated with 30–50% decline in number of cholinergic
neurons in the NBM of rats (Smith and Booze, 1995) and humans (de
Lacalle et al., 1991; Guela and Mesulam, 1994).
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